Nom du produit:5-Bromo-3-methyl-2-(methylthio)pyrimidin-4(3H)-one

IUPAC Name:5-bromo-3-methyl-2-(methylsulfanyl)-3,4-dihydropyrimidin-4-one

CAS:81560-06-7
Formule moléculaire:C6H7BrN2OS
Pureté:97%
Numéro de catalogue:CM544275
Poids moléculaire:235.1

Unité d'emballage Stock disponible Prix($) Quantité
CM544275-100mg in stock ŮƈǪ
CM544275-250mg in stock ƈŌƿ
CM544275-1g in stock ƿŤľ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:81560-06-7
Formule moléculaire:C6H7BrN2OS
Point de fusion:-
Code SMILES:O=C1N(C)C(SC)=NC=C1Br
Densité:
Numéro de catalogue:CM544275
Poids moléculaire:235.1
Point d'ébullition:
N° Mdl:
Stockage:2-8°C,stored under nitrogen

Category Infos

Pyrimidines
Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.

Column Infos

Vimseltinib
Vimseltinib (DCC-3014) is a potent and highly selective oral CSF1R kinase inhibitor that selectively and effectively inhibits CSF1R by utilizing the unique characteristics of the switch control region that regulates kinase conformational activation. The key phase 3 MOTION study conducted by vimseltinib in patients with giant cell tumor of the tendon sheath (TGCT) has shown positive results, and it is expected to submit a listing application to the FDA and the European Union next year.

Related Products